Trexquant Investment LP raised its stake in Cigna Corporation (NYSE:CI) by 294.7% during the second quarter, according to its most recent filing with the SEC. The fund owned 7,500 shares of the health services provider’s stock after buying an additional 5,600 shares during the period. Trexquant Investment LP’s holdings in Cigna Corporation were worth $1,255,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. boosted its stake in Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock worth $2,488,489,000 after buying an additional 16,289,943 shares during the last quarter. Vanguard Group Inc. boosted its stake in Cigna Corporation by 3.5% in the first quarter. Vanguard Group Inc. now owns 16,706,266 shares of the health services provider’s stock worth $2,447,301,000 after buying an additional 570,241 shares during the last quarter. State Street Corp boosted its stake in Cigna Corporation by 1.7% in the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock worth $1,631,451,000 after buying an additional 190,323 shares during the last quarter. Wellington Management Group LLP boosted its stake in Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock worth $1,577,075,000 after buying an additional 913,991 shares during the last quarter. Finally, Boston Partners boosted its stake in Cigna Corporation by 3.1% in the first quarter. Boston Partners now owns 3,604,693 shares of the health services provider’s stock worth $528,052,000 after buying an additional 108,880 shares during the last quarter. Hedge funds and other institutional investors own 87.61% of the company’s stock.

Shares of Cigna Corporation (CI) traded down 0.56% on Friday, reaching $177.03. The company’s stock had a trading volume of 1,034,361 shares. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $181.00. The stock has a 50-day moving average price of $173.66 and a 200-day moving average price of $160.28. The company has a market capitalization of $44.57 billion, a price-to-earnings ratio of 20.43 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same period in the previous year, the business earned $1.98 earnings per share. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. On average, equities research analysts forecast that Cigna Corporation will post $10.03 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/08/19/cigna-corporation-ci-position-boosted-by-trexquant-investment-lp-updated.html.

A number of equities research analysts have commented on CI shares. Jefferies Group LLC restated a “buy” rating and set a $178.00 target price (up previously from $172.00) on shares of Cigna Corporation in a research note on Sunday, April 23rd. Zacks Investment Research upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research note on Tuesday, April 25th. Stifel Nicolaus raised their target price on shares of Cigna Corporation from $170.00 to $175.00 and gave the stock a “buy” rating in a research note on Friday, May 5th. Royal Bank Of Canada raised their target price on shares of Cigna Corporation from $172.00 to $177.00 and gave the stock an “outperform” rating in a research note on Monday, May 8th. Finally, Deutsche Bank AG raised their target price on shares of Cigna Corporation from $172.00 to $175.00 and gave the stock a “buy” rating in a research note on Wednesday, May 10th. Three equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $180.44.

In related news, insider Michael W. Triplett sold 1,439 shares of Cigna Corporation stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $166.89, for a total value of $240,154.71. Following the sale, the insider now directly owns 26,199 shares in the company, valued at $4,372,351.11. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO David Cordani sold 153,168 shares of Cigna Corporation stock in a transaction on Monday, June 19th. The stock was sold at an average price of $170.20, for a total value of $26,069,193.60. Following the transaction, the chief executive officer now directly owns 421,162 shares of the company’s stock, valued at $71,681,772.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 243,463 shares of company stock worth $41,678,984. Company insiders own 1.30% of the company’s stock.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.